TUCHMAN ALAN J 4
4 · Synaptogenix, Inc. · Filed Feb 22, 2022
Insider Transaction Report
Form 4
TUCHMAN ALAN J
DirectorChief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-16+6,150→ 6,150 totalExercise: $7.29Exp: 2032-02-16→ Common Stock (6,150 underlying)
Footnotes (1)
- [F1]This option was issued on February 16, 2022 (the "Grant Date") under the Issuer's 2020 Equity Incentive Plan and will vest in equal quarterly installments over the four quarters following the Grant Date.